GREENFIELD, IN / ACCESS Newswire / June 26, 2025 / Today, Elanco Animal Health Incorporated (NYSE: ELAN) announced the release of its 2024 Impact Report, showcasing its efforts to enhance animal ...

Elanco’s recent launches could add 5% to overall growth in 2025, per William Blair. EMA panel gives positive opinion on Zenrelia; approval expected by Q3 end. Geopolitical tensions, Fed ...

Elanco is just the latest battle for Ancora—and not even the highest-profile one at the moment. Ancora also has its hands full in taking on Norfolk Southern, ...

Elanco reported 1Q sales of $1,205 million, ahead of consensus at $1,175 million, down 4% CC. Adjusting for the ERP (enterprise resource planning) switchover in 2023, ...

Greenfield-based Elanco Health on Monday announced the $295 million cash sale of future U.S. royalty and milestone rights for the human use of a medication typically used for dogs and cats.

Elanco Animal Health and Purdue University are partnering to create a three-acre research facility near the former site of the GM stamping plant in Indianapolis. The facility will be part of a new ...

Today, Elanco Animal Health Incorporated (NYSE: ELAN) announced the release of its 2024 Impact Report, showcasing its efforts to enhance animal care, not just improving the lives of animals but ...

GREENFIELD, Ind., June 26, 2025 /PRNewswire/ -- Today, Elanco Animal Health Incorporated (NYSE: ELAN) announced the release of its 2024 Impact Report, showcasing its efforts to enhance animal care ...

Elanco invites all stakeholders to explore the full 2024 Impact Report and looks forward to further advancing our purpose of Making Life Better for animals, customers, society, and our people in ...

GREENFIELD, Ind., June 26, 2025 /3BL/ - Today, Elanco Animal Health Incorporated (NYSE: ELAN) announced the release of its 2024 Impact Report , showc Tuesday, 02 January 2024 12:17 GMT عربي ...